| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9343(90)90349-I |
| P8608 | Fatcat ID | release_zg4gynct7nejrdb2u53pytxbeu |
| P698 | PubMed publication ID | 2393038 |
| P50 | author | Jerry Avorn | Q6183214 |
| P2093 | author name string | Baker MW | |
| Everitt DE | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | decision making | Q1331926 |
| insomnia | Q1869874 | ||
| P304 | page(s) | 357-362 | |
| P577 | publication date | 1990-09-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Clinical decision-making in the evaluation and treatment of insomnia | |
| P478 | volume | 89 |
| Q39012304 | A comparative study on the clinical decision-making processes of nurse practitioners vs. medical doctors using scenarios in a secondary care environment. |
| Q33806563 | Are prescribed medications effective in the treatment of insomnia complaints? |
| Q43875912 | Assessing the effects of an intervention by a pharmacist on prescribing and administration of hypnotics in nursing homes |
| Q24797576 | Attitudes towards treatment among patients suffering from sleep disorders. A Latin American survey |
| Q44130661 | Avoiding the blanket approach to insomnia. Targeted therapy for specific causes |
| Q34279204 | Defining basic services and de-insuring the rest: the wrong diagnosis and the wrong prescription. |
| Q52042697 | Diagnosis and treatment of outpatient insomnia by psychiatric and nonpsychiatric physicians |
| Q37024563 | Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the International Classification of Sleep Disorders (ICSD). |
| Q50962317 | General practitioners' prescribing patterns of benzodiazepine hypnotics: are elderly patients at particular risk for overprescribing? A report from the Møre & Romsdal Prescription Study. |
| Q48877535 | Insomnia. Use of a 'decision tree' to assess and treat |
| Q28366184 | Lifestyle drugs: issues for debate |
| Q35747888 | Management of insomnia in patients with chronic pain conditions |
| Q36745740 | Measuring clinical practice |
| Q48827759 | Mental comorbidity of chronic insomnia in general practice attenders using DSM-III-R. |
| Q42364720 | Ontario palliative care statement: a template for the rest of Canada |
| Q36966789 | Patient and clinician communication of self-reported insomnia during ambulatory cancer care clinic visits |
| Q41581489 | Physician responses to an educational intervention on improving their long-term prescribing of sedatives |
| Q44511458 | Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg. |
| Q34061310 | Prevalence and treatment of insomnia in general practice. A longitudinal study. |
| Q52001487 | Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. |
| Q73030874 | Sleep history is neglected diagnostic information. Challenges for primary care physicians |
| Q35665983 | The Importance of Residual Effects When Choosing a Hypnotic: The Unique Profile of Zaleplon |
| Q35202840 | The challenge of chronic insomnia: is non-nightly hypnotic treatment a feasible alternative? |
| Q33837360 | The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach |
| Q33736788 | Ways to minimize adverse drug reactions. Individualized doses and common sense are key. |
Search more.